Biolexis Therapeutics

American Fork, United States

Biolexis Therapeutics is a privately held biopharmaceutical company committed to developing novel targeted therapeutics.

$10.0M raised

Nov 2023

Series A

Health Care Pharmaceutical Therapeutics

Top Investors

Clarke Capital Partners

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Biolexis Therapeutics

How much funding has Biolexis Therapeutics raised?

Biolexis Therapeutics has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in November 2023.

Who are Biolexis Therapeutics's investors?

Biolexis Therapeutics's investors include Clarke Capital Partners.

Where is Biolexis Therapeutics headquartered?

Biolexis Therapeutics is headquartered in American Fork, United States.

What does Biolexis Therapeutics do?

Biolexis Therapeutics is a privately held biopharmaceutical company committed to developing novel targeted therapeutics.

What stage is Biolexis Therapeutics at?

Biolexis Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 29, 2023.

MLA

"Biolexis Therapeutics — Funding & Investors." VCBacked, November 29, 2023, https://www.vcbacked.co/company/biolexis-therapeutics. Accessed June 17, 2026.

APA

VCBacked. (2023). Biolexis Therapeutics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/biolexis-therapeutics

Wikipedia (cite web)

{{cite web |title=Biolexis Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/biolexis-therapeutics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 29, 2023.